Bicalutamide having Long Half Life [Design Issues]

posted by udayk  – India, 2019-10-04 14:06 (2102 d 15:49 ago) – Posting: # 20664
Views: 4,249

Dear All,

We need clarification on study design of BE of Bicalutamide 50mg tablets since, its long half life is around 150 hours and most of the available literatures have shown as parallel BE study with last time point as 672 hours and two-way cross over study with last time point as 672 hours.

Please suggest on study design of BE/BA study with Time-points to cover the AUC.

Regards,
Udaya Kumar K.
Biostatistician

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,680 registered users;
56 visitors (0 registered, 56 guests [including 14 identified bots]).
Forum time: 05:56 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5